Desenvolvimento fetal em ratas wistar tratadas com ipriflavona durante a fetogênese
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
The ipriflavone is a synthetic derivative of the isoflavone daidzein, marketed
with the aim of preventing and / or treating osteoporosis. It was verified in vitro
that ipriflavone (IP) induced apoptosis in gastric epithelial cells and inhibited
proliferation and DNA synthesis of bone tumor cells. The daidzein, the
precursor of ipriflavone, had anti-implantation effect in rats and reduced
production of progesterone in human trophoblast cells. Genistein is structurally
similar to ipriflavone, has harmful effects on the blastocysts of mice, cultured in
vitro and in vivo. The fetogenesis is a period of embryonic development in which
there is intense mitosis and cell proliferation, which characterize the growth and
differentiation of various organ systems, finishing the formation of reproductive
system and central nervous systems of final development of the limbs and face.
All these processes can be altered by the effects of iproflavone, but there are no
studies to assess them, the purpose of this study was to evaluate fetal
development in rats treated with aqueous solution of Ipriflavone during the
fetogênese. 60 rats were used at 10 days post-coitus (pc), maintained under
controlled temperature, humidity and ventilation, which were randomly
distributed in one control group - C (1 ml of distilled water) and three treated
groups T1, T2 and T3 that received, respectively, 300, 1500 and 3000mg/kg of ipriflavone, intragastric, from 16 to 20 pc. The animals were euthanized at 21º
days pc. Variables analyzed: maternal organ weights (liver, kidney, supra
kidney, spleen and ovary), length and fetal body weight, weight of placenta,
brain, liver, kidney and lung. Statistics gathering data analysis: ANOVA followed
by Dunnett test (α = 0.05). The experimental procedure was approved by the
Ethics Committee on Animal Experimentation of Federal University of Juiz de
Fora (Protocol No. 024/2008). Treatment with aqueous suspension of
ipriflavone caused no significant difference in any of the variables studied. We
can conclude that in the experimental model used, the ipriflavone did not cause
maternal toxicity and significant changes in fetal development.
Description
Keywords
Ipriflavona , Fetogênese , Ratos , Gestação , Desenvolvimento , Ipriflavone , Fetogenesis , Rats , Pregnancy , Development
Citation
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
